Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, T. F.
Right arrow Articles by Bilchik, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, T. F.
Right arrow Articles by Bilchik, A. J.
Related Collections
Right arrow Pathology
Right arrow Surgery
Annals of Surgical Oncology 8:150-157 (2001)
© 2001 Society of Surgical Oncology


ORIGINAL ARTICLES

Validation of Lymphatic Mapping in Colorectal Cancer: In Vivo, Ex Vivo, and Laparoscopic Techniques

Thomas F. Wood, MD, Sukamal Saha, MD, Donald L. Morton, MD, George J. Tsioulias, MD, DMSc, Decio Rangel, MD, William Hutchinson Jr., MD, Leland J. Foshag, MD and Anton J. Bilchik, MD, PhD

From the John Wayne Cancer Institute (TFW, SS, DLM, GJT, DR, WH, LJF, AJB), Santa Monica, California and the Department of Surgery (SS), McLaren Regional Medical Center, Michigan State University, Flint, Michigan.

Correspondence: Address correspondence to: Anton J. Bilchik, MD, PhD, John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404; Fax: 310-449-5261; Email: bilchika{at}jwci.org

Background: The use of lymphatic mapping (LM) is being investigated to improve the staging of colorectal cancer (CRC) and thereby identify patients who might benefit from adjuvant chemotherapy. This study evaluated in vivo, laparoscopic, and ex vivo approaches for the ultrastaging of CRC.

Methods: Seventy-five CRC patients were enrolled in a study of LM with peritumoral injection of isosulfan blue dye. LM was undertaken during open colon resection (OCR) in 64 patients, during laparoscopic colon resection (LCR) in 9 patients, and after specimen removal (ex vivo) in 2 patients. Ex vivo LM was also undertaken in 6 patients after unsuccessful in vivo LM. All nodes were examined by hematoxylin and eosin (H&E) staining; in addition, sentinel lymph nodes (SNs) were multisectioned and examined by immunohistochemical staining with cytokeratin (CK-IHC).

Results: At least one SN was identified in 72 patients (96%). In vivo LM identified SNs in 56 of 64 (88%) patients undergoing OCR and in 9 of 9 (100%) patients undergoing LCR. Ex vivo LM was undertaken as the initial mapping procedure in 2 cases of intraperitoneal colon cancer and after in vivo LM had failed in 6 cases of extraperitoneal rectal carcinoma; an SN was identified in 7 of the 8 cases. Focused examination of the SN correctly predicted nodal status in 53 of 56 OCR cases, 9 of 9 LCR cases, and 6 of 7 ex vivo cases. Multiple sections and CK-IHC identified occult micrometastases in 13 patients (17%), representing 10 OCR, 1 LCR, and 2 ex vivo cases.

Conclusions: LM of drainage from a primary CRC can be accurately performed in vivo during OCR or LCR. Ex vivo LM can be applied when in vivo techniques are unsuccessful and may be useful for rectal tumors. During LCR, colonoscopic injection can be used to mark the primary tumor and define the lymphatic drainage so that adequate resection margins are obtained. These LM techniques improve staging accuracy in CRC.

Key Words: Colorectal carcinoma • Sentinel node • Lymphatic mapping • Staging • Laparoscopic colon resection • Ex vivo.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
R. J. de Haas, D. A. Wicherts, M. G. G. Hobbelink, I. H. M. B. Rinkes, M. E. I. Schipper, J.-A. van der Zee, and R. van Hillegersberg
Sentinel Lymph Node Mapping in Colon Cancer: Current Status
Ann. Surg. Oncol., March 1, 2007; 14(3): 1070 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. J. Bilchik, M. DiNome, S. Saha, R. R. Turner, D. Wiese, M. McCarter, D. S. B. Hoon, and D. L. Morton
Prospective Multicenter Trial of Staging Adequacy in Colon Cancer: Preliminary Results
Arch Surg, June 1, 2006; 141(6): 527 - 534.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
C. Codignola, F. Zorzi, A. Zaniboni, S. Mutti, A. Rizzi, E. Padolecchia, and G. B. Morandi
Is there any Role for Sentinel Node Mapping in Colorectal Cancer Staging? Personal Experience and Review of the Literature
Jpn. J. Clin. Oncol., November 1, 2005; 35(11): 645 - 650.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
F. M. Smith, J. C. Coffey, N. M. Khasri, M. F. Walsh, N. Parfrey, E. Gaffney, R. Stephens, M. J. Kennedy, W. Kirwan, and H. P. Redmond
Sentinel Nodes Are Identifiable in Formalin-Fixed Specimens After Surgeon-Performed Ex Vivo Sentinel Lymph Node Mapping in Colorectal Cancer
Ann. Surg. Oncol., June 1, 2005; 12(6): 504 - 509.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. G. Dan, S. Saha, K. M. Monson, D. Wiese, E. Schochet, K. R. Barber, B. Ganatra, D. Desai, and S. Kaushal
1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal Tumors
Arch Surg, November 1, 2004; 139(11): 1180 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. Zaniboni and R. Labianca
Adjuvant therapy for stage II colon cancer: an elephant in the living room?
Ann. Onc., September 1, 2004; 15(9): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. J. Ellner, J. Mendez, D. R. Vera, C. K. Hoh, W. L. Ashburn, and A. M. Wallace
Sentinel Lymph Node Mapping of the Colon and Stomach Using Lymphoseek in a Pig Model
Ann. Surg. Oncol., July 1, 2004; 11(7): 674 - 681.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. L. Morton
Sentinel Node Mapping and an International Sentinel Node Society: Current Issues and Future Directions
Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 137S - 143S.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Saha, A. G. Dan, A. J. Bilchik, Y. Kitagawa, E. Schochet, S. Choudhri, L. T. Saha, D. Wiese, D. Morton, and M. Kitajima
Historical Review of Lymphatic Mapping in Gastrointestinal Malignancies
Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 245S - 249S.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T.E. Le Voyer, E.R. Sigurdson, A.L. Hanlon, R.J. Mayer, J.S. Macdonald, P.J. Catalano, and D.G. Haller
Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089
J. Clin. Oncol., August 1, 2003; 21(15): 2912 - 2919.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. J. Bilchik, D. T. Nora, L. H. Sobin, R. R. Turner, S. Trocha, D. Krasne, and D. L. Morton
Effect of Lymphatic Mapping on the New Tumor-Node-Metastasis Classification for Colorectal Cancer
J. Clin. Oncol., February 15, 2003; 21(4): 668 - 672.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. J. Feezor, E. M. Copeland III, and S. N. Hochwald
Significance of Micrometastases in Colorectal Cancer
Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. J. Bilchik and D. T. Nora
Lymphatic Mapping of Nodal Micrometastasis in Colon Cancer: Putting the Cart Before the Horse?
Ann. Surg. Oncol., July 1, 2002; 9(6): 529 - 531.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society of Surgical Oncology.